PRODUCT DESCRIPTION:

Ganciclovir Tablets are potent antiviral agents specifically developed for the prevention and treatment of cytomegalovirus (CMV) infections, especially in immunocompromised individuals such as transplant recipients and patients with advanced HIV/AIDS.

As a synthetic guanine derivative, Ganciclovir inhibits viral DNA replication, effectively controlling viral load in high-risk patients.

Available in 250 MG and 500 MG strengths, the product is manufactured in WHO-GMP compliant facilities, offering reliability, safety, and efficacy for hospital protocols and international procurement needs.

It is a crucial therapy in organ transplant programs and AIDS treatment plans across the globe.

Formulation & Presentation:

• Dosage Form: Tablets
• Presentation: Available in Blister Pack or HDPE Bottle (As per market requirement)
• Available Strengths:
  • Ganciclovir Tablets: 250 MG
  • Ganciclovir Tablets: 500 MG
• Route of Administration: Oral (As per physician’s discretion or therapeutic indication)

Therapeutic Indications:

• Treatment of CMV retinitis in immunocompromised patients
• Prophylaxis of CMV disease in organ transplant recipients
• Part of antiviral protocols for advanced HIV/AIDS patients
• Occasionally used in Epstein-Barr virus and HSV infections where resistant strains are suspected

Side Effects:

• COMMON:
  • Diarrhea
  • Nausea
  • Headache
  • Anemia
  • Neutropenia
  • Fever
• SERIOUS (RARE):
  • Bone marrow suppression (severe neutropenia, thrombocytopenia)
  • Hepatotoxicity
  • CNS effects (confusion, seizures, hallucinations)
  • Renal impairment
  • Reproductive toxicity (teratogenic/mutagenic potential)
• PRECAUTIONS:
  • Use with extreme caution in patients with renal impairment (dose adjustment required)
  • Regular monitoring of complete blood counts during prolonged therapy
  • Contraindicated in pregnant or lactating women unless clearly necessary
  • Avoid use with other myelosuppressive drugs
  • Monitor for signs of neurotoxicity in high-risk patients